Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 1, 2013, Pages 29-34

  Yoshimura, Satoshi ^a   Isobe, Noriko ^a   Matsushita, Takuya ^a   Yonekawa, Tomomi ^a   Masaki, Katsuhisa ^a   Sato, Shinya ^a   Kawano, Yuji ^b   Kira, Jun Ichi ^a   Miyamoto, Katsuichi ^c   Kusunoki, Susumu ^c   Nakatsuji, Yuji ^d   Mochizuki, Hideki ^d   Ochi, Kazuhide ^e   Matsumoto, Masayasu ^e   Kanda, Takeshi ^f   Ochi, Hirofumi ^g   Miki, Tetsuro ^g   Okada, Kazumasa ^h   Tsuji, Sadatoshi ^h  

^a KYUSHU UNIVERSITY   (Japan)

^b EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KINKI UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e HIROSHIMA UNIVERSITY   (Japan)

^f YAMAGUCHI UNIVERSITY   (Japan)

^g EHIME UNIVERSITY   (Japan)

^h UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4 ANTIBODY; EPSTEIN BARR VIRUS ANTIGEN; HLA DPB1 ANTIGEN; HLA DRB1 ANTIGEN; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOTYPE; HELICOBACTER PYLORI; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; PRIORITY JOURNAL; SEROLOGY; VARICELLA ZOSTER VIRUS;

EID: 84871217871     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-302925     Document Type: Article

References (40)

1. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:2106-12. (Pubitemid 39626806)
2. Lennon VA, Kryzer TJ, Pittock SJ, et al. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005;202:473-7. (Pubitemid 41186945)
3. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol 2007;6:805-15. (Pubitemid 47238676)
4. Kira J, Kanai T, Nishimura Y, et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996;40:569-74. (Pubitemid 26357880)
5. Nakashima I, Fujihara K, Miyazawa I, et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatry 2006;77:1073-5. (Pubitemid 44338534)
6. Matsuoka T, Matsushita T, Kawano Y, et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007;130:1206-23. (Pubitemid 47355945)
7. Tanaka K, Tani T, Tanaka M, et al. Anti-aquaporin 4 antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions. Mult Scler 2007;13:850-5. (Pubitemid 351540855)
8. Matsushita T, Isobe N, Matsuoka T, et al. Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese. Mult Scler 2009;15:834-47.
9. Giovannoni G, Ebers G. Multiple sclerosis: the environment and causation. Curr Opin Neurol 2007;20:261-8. (Pubitemid 46743106)
10. Yamasaki K, Horiuchi I, Minohara M, et al. HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain 1999; 122:1689-96. (Pubitemid 29425672)
11. Matsushita T, Matsuoka T, Isobe N, et al. Association of the HLA-DPB1&z.ast;0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders. Tissue Antigens 2009;73:171-6.
12. Wang H, Dai Y, Qiu W, et al. HLA-DPB1&z.ast;0501 is associated with susceptibility to anti-aquaporin-4 antibodies positive neuromyelitis optica in southern Han Chinese. J Neuroimmunol 2011;233:181-4.
13. Levin LI, Munger KL, O'Reilly EJ, et al. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol 2010;67:824-30.
14. Li W, Minohara M, Su JJ, et al. Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population. J Neuroimmunol 2007;184:227-31. (Pubitemid 46366004)
15. Li W, Minohara M, Piao H, et al. Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica. Mult Scler 2009;15:1411-21.
16. Ishizu T, Osoegawa M, Mei FJ, et al. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 2005;128:988-1002. (Pubitemid 40675455)
17. Tanaka M, Matsushita T, Tateishi T, et al. Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis. Neurology 2008;71:974 -81.
18. Ochi H, Wu XM, Osoegawa M, et al. Tc1/Tc2 and Th1/Th2 balance in Asian and Western types of multiple sclerosis, HTLV-I-associated myelopathy/tropical spastic paraparesis and hyperIgEaemic myelitis. J Neuroimmunol 2001;119:297-305. (Pubitemid 32918338)
19. Wang HH, Dai YQ, Qiu W, et al. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse. J Clin Neurosci 2011;18:1313-17.
20. Mamata Y, Hakki A, Newton C, et al. Differential effects of Chlamydia pneumoniae infection on cytokine levels in human T lymphocyte- and monocyte-derived cell cultures. Int J Med Microbiol 2007;297:109-15. (Pubitemid 46386490)
21. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-9. (Pubitemid 43958540)
22. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria'. Ann Neurol 2005; 58:840-6. (Pubitemid 41746873)
23. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444-52. (Pubitemid 14237132)
24. Poser S, Ritter G, Bauer HJ, et al. HLA-antigens and the prognosis of multiple sclerosis. J Neurol 1981;225:219-21. (Pubitemid 11070497)
25. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically de finite multiple sclerosis. Brain 1997;120:2059-69. (Pubitemid 27493740)
26. Isobe N, Yonekawa T, Matsushita T, et al. Quantitative assays for anti-aquaporin-4 antibody with subclass analysis in neuromyelitis optica. Mult Scler 2012;18:1541-51.
27. Jarius S, Aboul-Enein F, Waters P, et al. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 2008;131:3072-80.
28. Hinson SR, McKeon A, Fryer JP, et al. Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells. Arch Neurol 2009;66:1164-7.
29. Brum DG, Barreira AA, dos Santos AC, et al. HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis. Mult Scler 2010;16:21-9.
30. Deschamps R, Paturel L, Jeannin S, et al. Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population. Mult Scler 2011;17:24-31.
31. Laheij RJ, Straatman H, Jansen JB, et al. Evaluation of commercially available Helicobacter pylori serology kits: a review. J Clin Microbiol 1998;36:2803-9. (Pubitemid 28429395)
32. Hermann C, Graf K, Groh A, et al. Comparison of eleven commercial tests for Chlamydia pneumoniaespecific immunoglobulin G in asymptomatic healthy individuals. J Clin Microbiol 2002;40:1603-9. (Pubitemid 34493126)
33. Bagos PG, Nikolopoulos G, Ioannidis A. Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis. Mult Scler 2006;12:397-411. (Pubitemid 44132580)
34. Kamradt T, Goggel R, Erb KJ. Induction, exacerbation and inhibition of allergic and autoimmune diseases by infection. Trend Immun 2005;26:260-7. (Pubitemid 41556849)
35. Caruso R, Pallone F, Monteleone G. Emerging role of IL-23/IL-17 axis in H pylori-associated pathology. World J Gastroenterol 2007;13:5547-51. (Pubitemid 350031473)
36. Minohara M, Matsuoka T, Li W, et al. Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: positive correlation with disease severity. J Neuroimmunol 2006;178:156-60. (Pubitemid 44307343)
37. Doi H, Matsushita T, Isobe N, et al. Hypercomplementemia at relapse in patients with anti-aquaporin-4 antibody. Mult Scler 2009;15:304-10.
38. Gasbarrini A, Franceschi F, Tartaglione R, et al. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998;352:878. (Pubitemid 28416725)
39. Hohmann I, Bill RM, Kayingo G, et al. Microbial MIP channels. Trends Microbiol 2000;8:33-8. (Pubitemid 30066382)
40. Qiu W, James I, Carroll WM, et al. HLA-DR allele polymorphism and multiple sclerosis in Chinese populations: a meta-analysis. Mult Scler 2010;17:382-8.